Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial cell dysfunction: can't live with it, how to live without it.

Michael S Goligorsky1

  • 1Department of Nephrology and Renal Research Institute, Department of Medicine, New York Medical College, Valhalla, New York 10595, USA. Michael_Goligorsky@nymc.edu

American Journal of Physiology. Renal Physiology
|April 12, 2005
PubMed
Summary

Endothelial cell dysfunction contributes to cardiovascular diseases and chronic kidney disease complications. Understanding its molecular mechanisms and developing targeted therapies are crucial for managing these conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparative analysis of CFD and LBM for investigating the effects of endothelial glycocalyx on the bifurcating blood flow.

Microvascular research·2026
Same author

Endothelial Glycocalyx: From Microscope Stage to Bedside.

Nephron·2026
Same author

Highlights of the First 100 Years of Publications on Kidney Disease in The American Journal of Pathology.

The American journal of pathology·2025
Same author

Permissive role of vascular endothelium in fibrosis: focus on the kidney.

American journal of physiology. Cell physiology·2024
Same author

Glomerular microcirculation: Implications for diabetes, preeclampsia, and kidney injury.

Acta physiologica (Oxford, England)·2023
Same author

Endothelial Glycocalyx and Cardiomyocyte Damage Is Prevented by Recombinant Syndecan-1 in Acute Myocardial Infarction.

The American journal of pathology·2023

Area of Science:

  • Cardiovascular Science
  • Nephrology
  • Molecular Biology

Background:

  • Endothelial cell dysfunction is a key factor in cardiovascular diseases and chronic kidney disease complications.
  • The precise definition, pathophysiology, and therapeutic strategies for endothelial dysfunction remain unclear.

Purpose of the Study:

  • To summarize molecular mechanisms underlying endothelial dysfunction.
  • To propose a model of endothelial dysfunction based on interconnected functions.
  • To discuss potential therapeutic strategies for endothelial dysfunction.

Main Methods:

  • Review of molecular mechanisms including hyperhomocysteinemia, elevated asymmetric dimethylarginine, and advanced glycation end products.
  • Development of a conceptual model for endothelial dysfunction.

Related Experiment Videos

  • Discussion of therapeutic interventions.

    • Main Results:

    • Hyperhomocysteinemia, elevated asymmetric dimethylarginine, and AGE-modified proteins contribute to a proatherogenic, prothrombogenic, and proinflammatory endothelial phenotype.
    • A model highlighting the interconnectedness of endothelial functions in dysfunction is presented.

    Conclusions:

    • Endothelial cell dysfunction is a complex syndrome with multifactorial molecular underpinnings.
    • Further research is needed to clarify pathophysiology and optimize therapeutic approaches for endothelial dysfunction.